Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bancroft Charles A
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   168,937    

Indirect Shares

   300,000      
Direct Value   $6,416,008    

Indirect Value

   $12,681,000      
Total Shares   468,937      
Total Value   $19,097,008      


Bristol-Myers Squibb Co $5,813,562 Colgate Palmolive Co $519,152 Kodiak Sciences Inc. $83,293 Bristol-Myers Squibb Co $5,813,562 Colgate Palmolive Co $519,152 Kodiak Sciences Inc. $83,293
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bristol-Myers Squibb Co BMY EVP, Head of Integration 2020-03-10 137,534 2020-03-10 300,000    Premium*  
            Colgate Palmolive Co CL Director 2018-05-14 5,455 2017-05-15 0    Premium*  
            Kodiak Sciences Inc. KOD Director 2020-04-02 25,948 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMY Bristol-Myers Squibb Co EVP, Head of Integration   •       –      –    2020-03-10 4 GA $0.00 $0 I/I 300,000 300,000 0 -
BMY Bristol-Myers Squibb Co EVP, Head of Integration   •       –      –    2020-03-10 4 GD $0.00 $0 D/D 300,000 92,309 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-03 4 OE $0.00 $0 D/D 121,014 199,850 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2018-03-10 4 OE $0.00 $0 D/D 91,318 363,739 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2017-03-10 4 OE $0.00 $0 D/D 87,324 289,293 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4/A OE $0.00 $0 D/D 75,618 240,329 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4 OE $0.00 $0 D/D 75,618 247,158 0 -
BMY Bristol-Myers Squibb Co EVP, Head of Integration   •       –      –    2020-03-10 4 OE $0.00 $0 D/D 71,868 153,637 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2013-03-07 4 OE $0.00 $0 D/D 69,542 142,348 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-07-29 4 S $51.06 $3,452,532 D/D (67,621) 96,564 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2019-03-10 4 OE $0.00 $0 D/D 62,255 411,547 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-03 4 D $53.49 $3,285,302 D/D (61,419) 152,303 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-02 4 OE $0.00 $0 D/D 57,926 170,514 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-02-14 4 S $54.35 $2,878,285 D/D (52,963) 77,303 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2019-02-28 4 OE $17.51 $925,999 D/D 52,884 392,690 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2012-12-17 4 OE $23.14 $1,191,115 D/D 47,125 113,920 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2012-12-17 4 S $32.77 $1,403,998 D/D (42,844) 71,076 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2018-03-10 4 D $67.92 $2,731,131 D/D (40,211) 336,121 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2017-03-10 4 D $58.32 $2,333,267 D/D (40,008) 261,369 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2018-02-23 4 OE $22.14 $829,364 D/D 37,460 302,348 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4/A D $64.94 $2,365,569 D/D (36,427) 214,895 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4 D $64.94 $2,365,569 D/D (36,427) 221,724 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-02-14 4 OE $22.73 $870,038 D/D 36,251 130,266 0 -
BMY Bristol-Myers Squibb Co EVP, Head of Integration   •       –      –    2020-03-10 4 D $57.93 $1,930,286 D/D (33,321) 137,534 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2013-03-07 4 D $37.53 $1,179,530 D/D (31,429) 119,015 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us